The Everwell Hub is our comprehensive, integrated platform for adherence and patient management. Health care staff can log into a single portal to register and follow up with patients, whose adherence reports from any of our integrated technologies appear side-by-side including 99DOTS, evriMED devices, and VOT.
Deployed alongside Nikshay in India, and as a standalone platform in other country settings, the Hub supports patient management for over 2 million patients per year, for over 12 thousand healthcare staff.
99DOTS is a low-cost engagement tool using basic mobile phones and augmented packaging for patients taking anti-Tuberculosis medication. Each day, patients send a free call to a number revealed after dispensing their medication. Based on their adherence and connection to the Hub, programs can differentially treat patients and escalate cases of non-adherence.
99DOTS has been deployed alongside the public and private sector TB program in India since 2015 - 99DOTS is projected to reach 250,000 patients from 6 countries by 2019.
Everwell Health Solutions is a Bangalore-based social enterprise that spun out of Microsoft Research India in 2015 by co-founders Andrew Cross and Bill Thies. Joined by Nakull Gupta, they began building a team in 2016 to champion their flagship work in digital adherence monitoring, 99DOTS, out of research and into large scale uptake in India. During their time at Microsoft Research India, they were a part of a team focusing on technology for emerging markets and social impact. The aim was to understand technology usage in areas where access to mobile phones and other devices had become cheaper and more accessible to a broader range of users, especially in domains like healthcare, education, agriculture, and microfinance. The inception of 99DOTS leveraged experience for how to design technology interventions for development with a list of guidelines which would define the approach to work at Everwell:
Technology is an enabler of human intent, not as a replacement
Designs should be low-cost, patient-centric, and use existing technology wherever possible
There should be a clear need, or “pull”, from the community of users and developed in collaboration with partners who have field experience
Ideas should rapidly iterate and first demonstrate feasibility, acceptance, and impact before scale
There should be a clear plan for long-term sustainability and scale at the outset
Through support by the Bill & Melinda Gates Foundation, USAID, and DfID and in close collaboration with public and private sector TB care in India, 99DOTS was scaled across India in various treatment settings. Based on the feasibility and scalability of the deployment in India, other countries expressed interests in piloting 99DOTS.
Everwell developed strong collaborations with other partners working on both adherence solutions and patient management, and continued to develop the software platform beyond 99DOTS to extend to other adherence solutions like Wisepill’s evriMED device and SureAdhere's video-observed therapy. The new Everwell Hub incorporated lab results, patient tracking, staff management, and both summary and detailed reports on treatment. The Hub integrated with the national ICT system called Nikshay and explored applications in other disease states dependent on adherence like HIV.
Everwell has a diverse and growing team dedicated to realizing the our mission to innovate and develop appropriate technologies to ensure that every patient is empowered to make a full recovery. We’re actively looking for other partners to leverage adherence solutions like 99DOTS and the technical Everwell Hub platform.
Our team comes from diverse backgrounds spanning engineering, research, design, healthcare, capacity building, and counseling, all dedicated to building user-centric tools and systems to support healthcare programs.
We're looking to expand our team with people that are passionate about our mission, have expertise in a relevant domain and want to grow alongside us! If you're excited to join the challenging and innovative work at Everwell,